Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00196651
Status:
TERMINATED
Last Update Posted:
2005-09-20
First Post:
2005-09-12
Brief Title:
HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Organization Data
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Class:
OTHER_GOV
Study ID:
ANRS 095 PRIMOVAC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |